Technology News and Research

RSS

Life Technologies reports fourth-quarter and fiscal year results ended December 31, 2009

Life Technologies Corporation today announced results for its fourth quarter and full year ending December 31, 2009. Non-GAAP revenue for the fourth quarter was $874 million, resulting in full year non-GAAP revenues of $3.30 billion, an increase of 5 percent over the $3.14 billion reported for 2008, as if Invitrogen and Applied Biosystems had been combined.

From Danaher 28 Jan 2010

Cenduit announces strategic business alliance with invivodata

Cenduit, LLC, and invivodata, inc., today announce a strategic business alliance to further improve clinical trial efficiencies by adding the scientific and operational benefits of invivodata’s electronic Patient Reported Outcomes (ePRO) solutions to the proven efficiencies of Cenduit‘s Interactive Response Technology solution (IRT).

28 Jan 2010

NBTY announces record results for fiscal first quarter

NBTY, Inc. (NYSE: NTY), a leading global manufacturer and marketer of nutritional supplements, today announced record results for the fiscal first quarter ended December 31, 2009.

28 Jan 2010

ZOLL Medical, HealthTrust Purchasing Group enter into purchasing agreement

ZOLL Medical Corporation, a manufacturer of medical devices and related software solutions, announced today that HealthTrust Purchasing Group, LP (HealthTrust), a leading healthcare group purchasing organization (GPO), has entered into a purchasing agreement with ZOLL for its therapeutic temperature management equipment.

28 Jan 2010

Encision reports financial results for third-quarter of fiscal year 2010

Encision Inc., a medical device company owning patented surgical technology that is emerging as a standard of care in minimally-invasive surgery, reported its financial results for its third quarter of fiscal year 2010.

28 Jan 2010

Christiana Care Health System introduces COPE technology for common diagnoses

Christiana Care Health System is taking a giant leap forward toward a comprehensive Electronic Health Record with the launch of Computerized Provider Order Entry (CPOE), technology that makes it easier, more efficient and safer for doctors to order tests and medications.

28 Jan 2010

Sexuality publishing portfolio gains key journal

Starting in 2010, Springer will publish the journal Sexuality Research and Social Policy. All aspects of sexual behavior are covered in the journal, including a unique focus on lesbian, gay, bisexual, and transgender populations. The journal was previously published by the University of California Press.

28 Jan 2010

Transcend Services announces unaudited financial results for fourth-quarter of 2009

TRANSCEND SERVICES, INC., a leading provider of medical transcription services to the U.S. healthcare market, today announced its unaudited financial results for the fourth quarter and year ended December 31, 2009.

28 Jan 2010

New research raises concerns over cost-benefits and NHS treatments

New research by health economists at the University of York has raised concerns over any move to broaden the range of costs and economic benefits considered in the analysis of new NHS treatments.

28 Jan 2010

New insight into reprogramming of cells

A discovery by Babraham scientists brings new insight into how cells are reprogrammed and a greater understanding of how the environment, or factors like nutritional signals, can interact with our genes to affect health. As an embryo develops, cells acquire a particular fate, for example becoming a nerve or skin cell. The findings, reported online in the journal Nature, pinpoint a protein called AID as being important for complete cellular reprogramming in mammals.

28 Jan 2010

Study shows ActiveHealth's VBID programs increase adherence to medications

ActiveHealth Management (ActiveHealth®), a subsidiary of Aetna, today announced the publication of a paper in the February issue of Health Affairs. The paper demonstrates that properly structured value-based insurance design (VBID) programs can be effective at increasing adherence to drug regimens for specific chronic medical conditions without increasing overall costs.

28 Jan 2010

Onset Therapeutics expands its sales force to create nationwide presence

Onset Therapeutics LLC, a specialty pharmaceutical company focused in dermatology, today announced that the Company’s recent growth and future opportunities have facilitated an expansion of its field sales organization to cover more than twenty-five additional major metropolitan areas.

28 Jan 2010

JST chooses Scopus Custom Data to conduct citation linkage analysis

Elsevier announced today that Scopus Custom Data, the underlying source of Scopus.com, the world's largest abstract and citation database, was chosen by Japan Science and Technology (JST) to conduct citation linkage analysis between scientific articles and patents.

28 Jan 2010

Alli boosts weight loss and reduces excess visceral fat

New studies show that overweight and obese people using alli® (orlistat 60 mg) with a reduced calorie, lower-fat diet can significantly reduce weight, visceral fat, and waist circumference and therefore may reduce their risk of type 2 diabetes, hypertension, heart disease and stroke.

28 Jan 2010

IsoRay ships first set of Cesium-131 brachytherapy seeds to Canada

IsoRay, Inc. announced today that it has successfully shipped the first set of Cesium-131 brachytherapy seeds to a Canadian customer for the purpose of furthering research and development of Cesium-131 in Canada. Cesium-131 is currently approved by Health Canada for the treatment of low-risk prostate cancers and has been cleared by the US FDA for treatment of a wide variety of malignant disease (e.g. prostate, head and neck, brain, breast, lung, eye, etc.).

28 Jan 2010

Radiation exposure from whole body scanners has little risk, says ACR

In the wake of the failed attempt by would-be bomber Umar Farouk Abdulmutallab to destroy Northwest flight 253 as it prepared to land in Detroit on Christmas day, airports around the world are considering mandatory installations of full-body (whole body) scanners including backscatter systems. Numerous media organizations have reported on whether radiation exposure from these systems poses a health risk to those who are scanned.

28 Jan 2010

Merck receives marketing authorization for ELONVA

Merck & Co., Inc., which operates outside the U.S. and Canada as MSD, today announced the European Commission (EC) approval of ELONVA® (corifollitropin alfa injection). ELONVA is indicated for controlled ovarian stimulation (COS) in combination with a GnRH antagonist for the development of multiple follicles in women participating in an assisted reproductive technology (ART) program.

28 Jan 2010

Mercadien Technologies announces availability of MCare web-based service

Mercadien Technologies, a leader in risk management, information governance and managed IT support solutions today announced the general availability of its MCare(TM) solution, a web-based service that monitors the health status of business-critical devices and applications, remotely diagnosing problems before they occur.

28 Jan 2010

NNSA helps funding development of domestic radioisotope supply

SNM applauds a move by the U.S. Department of Energy's National Nuclear Security Administration (NNSA) to help fund the development of a domestic supply of radioisotopes, which are used to help millions of patients each year through the diagnosis and staging of cancer, thyroid and heart disease.

28 Jan 2010

One Medical Group announces the availability of online appointment scheduling for members

One Medical Group, the modern medical practice that's reinventing primary care, today announced the availability of online appointment scheduling for its members in San Francisco and New York City.

28 Jan 2010